Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07884123
NA

Milk Beta Caseins on Digestive Discomfort, Gastric Emptying

Sponsor: Purdue University

View on ClinicalTrials.gov

Summary

A1 and A2 β-casein are genetic variants of β-casein in cow's milk that differ by a single amino acid at position 67. Digestion of A1 β-casein may result in greater release of beta-casomorphin-7 (BCM-7), an opioid peptide that may influence gastrointestinal function. Previous work from our group in lactose maldigesters found differences in gastric emptying following consumption of A1/A2 milk compared with A1 protein-free (A1PF) milk. This randomized, masked, crossover study evaluated whether opioid receptor blockade with oral naloxone influenced gastric emptying following consumption of A1/A2 milk compared with A1PF milk in lactose maldigesters. Participants consumed each milk treatment with 2 mg oral naloxone during separate study visits. Gastric volume was measured using magnetic resonance imaging (MRI) over 120 minutes, and gastrointestinal symptoms were assessed. The study was designed to investigate whether opioid receptor signaling contributes to differences in gastric emptying between A1/A2 milk and A1PF milk.

Official title: Comparing the Gastro-Intestinal Transit Time of Commercial Milk Containing A1 β-casein in Presence of the Opioid Antagonist Naloxone

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2025-01-30

Completion Date

2026-01-30

Last Updated

2026-10-20

Healthy Volunteers

No

Interventions

OTHER

A1/A2 milk with oral naloxone

Participants consumed A1/A2 milk at a volume calculated to provide 0.5 g lactose/kg body weight, using the formula: milk volume (mL) = \[0.5 g lactose × body weight (kg) / 11 g lactose\] × 245 mL milk. Participants also received 2 mg oral naloxone during the MRI intervention visit.

OTHER

A1PF milk with oral naloxone

Participants consumed A1/A2 milk at a volume calculated to provide 0.5 g lactose/kg body weight, using the formula: milk volume (mL) = \[0.5 g lactose × body weight (kg) / 11 g lactose\] × 245 mL milk. Participants also received 2 mg oral naloxone during the MRI intervention visit.

Locations (1)

Clinical Research Center

West Lafayette, Indiana, United States